Received 30 April 2016; accepted 4 June 2016; published 7 June 2016
The stem cells field represents an area of particular interest for scientific research. Stem cells are undifferentiated cells having a property of self-renewal and further differentiate into various types of specialized cells as shown in Table 1   . These stem cells can be found in a number of adult tissues including skin, adipose tissues  , peripheral blood   , bone marrow, pancreas, intestine, brain, hair follicles, as well as in the dental pulp cells   . Studies have shown that the dental pulp tissue can also be used to derive Mesenchymal Stem Cells (MSCs) when tissue is grown in culture  .
The results so far obtained give good expectations for the use of stem cells in clinical trials. Stem cell research has expanded well due to their usefulness in regenerative therapies for improving the life of patients suffering from various genetical and neurological diseases  . New therapeutic strategies have been made possible thanks to great advancements in stem cell biology, with the aim of regenerating tissues injured by disease  . Based on the ability of stem cells to rescue and/or repair injured tissue and partially restore organ function, multiple types of stem/progenitor cells have been speculated  .
Tissue engineering is an interdisciplinary field that connects various scientific aspects from engineering, materials science, biology, and medicine  .
The aim of this review is mainly highlighting the importance of DPSCs, differentiation and their applications in regenerative medicine.
2. Materials and Methods
MSCs were first described in 1976 by Friedenstein and colleagues and are more recently defined by The International Society of Cellular Therapy based on an important cellular property which is the ability of the cell to differentiate into osteocytes, adipocytes, and chondrocyte  . MSCs constitutes a heterogeneous population of cells and there are two main types of stem cells, embryonic and non-embryonic. Embryonic Stem Cells (ESCs) are derived from the inner cell mass of the blastocyst and can differentiate into cells of all three germ layers   . On the other hand, non-embryonic stem cells, mostly adult stem cells, are already somewhat specialized and have limited differentiation potential  . They can be isolated from various tissues and are currently the most commonly used seed cells in regenerative medicine  .
MSC are generated through enforced expression of defined transcription factors, which reset the fate of somatic cells to an embryonic stem-cell-like state  . MSCs have a rapid proliferation ability, achieving a thousand fold expansion of cell number in a two- to three-week period. However, inappropriate expansion may
Table 1. Normal differentiation pathways of adult stem cells from various tissues and cells.
Scheme 1. A flow diagram reflecting the literatures screening process.
reduce the quality of MSCs  . It is known that extensive in vitro culture induces cellular senescence that is associated with growth arrest and apoptosis. In addition, particular therapeutic properties of MSCs may be lost during prolonged culture  .
Embryonic stem cells and non-embryonic stem cells have all been explored as potential therapeutic strategies for a number of diseases  . One type of adult stem cells, mesenchymal stem cells, has generated a great amount of interest in the field of regenerative medicine due to their unique biological properties  .
Dental pulp is a soft connective tissue within the dental crown, it is an interesting source of adult stem cells because of the large amount of cells present and it is considered to be a non invasive process of extraction of MSCs from dental pulp tissue compared to other adult tissue sources   . Dental pulp tissue is thought to be derived from migrating neural crest cells during development   .
Dental pulp contains mesenchymal stem cells defined as Dental Pulp Stem Cells (DPSCs). DPSCs are obtained from human permanent and primary teeth, human wisdom teeth, human exfoliated deciduous teeth (SHEDs), and apical papilla   . Other sources of dental stem cells are the periodontal ligament, which houses Periodontal Ligament Stem Cells (PDLSCs), and the dental follicle, which contains Dental Follicle Progenitor Cells (DFPCs)  . During the development of teeth, there is an interaction between epithelial cells of dental pulp which lead to the differentiation of ameloblasts and odontoblasts, resulting into deposition of specialized mineralized matrices, i.e., enamel and dentin respectively. The inner area of dental pulp chamber contains a highly proliferative stem/progenitor cells possessing a self-renewal and differentiation properties  . It has been shown that after teeth eruption, there is an induction of reparative dentin formation which protects dental pulp from further degradation. DPSCs or stem cells from human exfoliated deciduous teeth (SHED) cells require a longer time for initial colony formation than other somatic cells. Third molar teeth derived cells differentiate into odontoblasts and secrete 3 D like crystal structure in vitro. Figure 1 shows calcium phosphate crystals secreted from DPSCs cells in a culture experiment  . It has been shown that DPSCs can be differentiated by modulation with growth factors, transcriptional factors, extracellular matrix proteins and receptor molecules into different cell types include odontoblast, osteoblast, chondrocyte, cardiomyocytes, neuron cells, adipocyte, corneal epithelial cell, melanoma cell and insulin secreting Beta cells  . DPSCs usually remain quiescent when they are within the dental pulps, but respond quickly after injury. Theses DPSCs have a high proliferative capacity and immediately differentiate into odontoblasts, osteoblasts, and chondrocytes to produce dentin, bone, and cartilage tissues respectively for this repair process  .
Figure 1. Calcium phosphate crystals secreted by dental pulp stem cells stained using silver and Giemsa in culture  .
5. Isolation of DPSC
Isolation of stem cells from human dental pulp could be done by several methods based on many experiments and investigations. Some of these methods explained in this review.
1) Raoof et al. 2014 
Method of isolation: 3 different methods for isolation of DPSCs from dental pulp tissue:
a) Dental pulp tissue is digested with collagenase or dispase enzyme and isolated trypsinised cells are plated in culture dishes;
b) They have explanted undigested dental pulp small tissue pieces directly to petridishes; and
c) Dental pulp tissues are initially trypsinised and then small tissue pieces are explanted to petridishes for their outgrowth.
They have grown these cultures in Minimum Essential Medium (MEM) supplemented with 20% Fetal Bovine Serum (FBS) at 37˚C with 5% CO2 and 90% humidity in CO2 incubator.
Result: The third method gives better cell outgrowth with achieving confluency at 60% within 2 days of culture.
They have recommended the third method for isolation of DPSCs from dental pulp.
2) Lindemann et al. 2014 
Method of isolation: They have isolated dental pulp cells from 7 days old non-cryopreserved and cryopreserved human deciduous teeth and culture them simultaneously.
Result: No change in differentiating and immunophenotype properties of both these cells. But there is a change in the morphology, proliferative capacity of cryopreserved cells than non-cryopreserved cells.
3) Lin et al. 2014 
Method of isolation: Human DPSCs isolated from extracted teeth are frozen and then stored at −196˚C for 24 h. During freezing, the cells are suspended in freezing media containing 10% dimethylsulfoxide (DMSO).
Result: when the freezing medium is DMSO free, the survival rates of revived DPSCs increase by 2 to 2.5 folds.
4) Gioventù et al. 2012 
Method of isolation: They have studied 4 human deciduous whole teeth, cryopreserved by making micro- channels into the tooth with the help of laser beam and then preserve these cells at −80˚C.
Result: This method saves a time in isolating DPSCs before cryopreservation and thus reduces the initial costs and workload of tooth banking. The DPSCs cells isolated by this method have shown normal morphology, cell viability and proliferation rate as well as maintain normal mesenchymal phenotype, similar to those of cells isolated from fresh non-cryopreserved teeth.
They have further shown that DPSCs isolated without laser piercing have significant loss of cell viability and proliferation rate as compared to teeth cryopreserved by leaser piercing.
6. Differentiation of DPSC
DPSC represent a rapidly proliferating cell population that readily differentiates into the osteoblastic, neural, myocytic, and hepatocytic lineages. This multi-lineage capacity of these DPSC suggests that they may have a more broad therapeutic application than lineage-restricted adult stem cell populations  .
DPSCs differentiate into different kinds of cells and tissues and their multi-potency has been compared to those of Bone Marrow Stem Cells (BMSCs). It has been demonstrated that proliferation, availability, and cell number of DPSCs are greater than BMSC  .
Stem Cells from Apical Papilla (SCAP) are the cells which are found at the tooth root apex. They have higher proliferation rates as well as have a differentiation property in vitro similar to DPSCs. They are capable of differentiating into odontoblast cells and produce dentin in vivo  . Due to their higher proliferative potential, SCAPs are also suitable for cell-based therapy for formation of apex roots  .
Human periodontal ligament stem cells (PDLSCs) can differentiate into cementoblast-like cells. They also have a capacity to form connective tissue which is rich in collagen I fibers  .
7. Differentiation Markers
LIF gene is called as Leukemia Inhibitory Factor and involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells. It plays a role in immune tolerance at the maternal fetal interface  . LIF derives its name from its ability to induce the terminal differentiation of myeloid leukemic cells  . The other differentiating marker is a Keratin18. It is a Keratin Associated-Protein (KAP) which forms a matrix of keratin intermediate filaments of cell cytoskeleton structure. Keratin 8, Keratin 18, and keratin 19 are used as a marker for epithelial cells and differentiate from hematopoietic cells  .
8. Application of DPSC
Suitable stem cells for tissue engineering should be able to differentiate into the target tissue/organ and should be easily collected and prepared to provide a further benefit to ensure the safety of the patient. DPSCs hold great clinical potential due to their differentiation capacity and easy accessibility.
1) De novo pulp regeneration 
When the entire pulp tissue is lost, regeneration requires the de novo creation of pulp. In order to create functional pulp for clinical application, several issues must be considered: first, regenerated pulp tissue must be vascularized, even through the blood supply occurs only from the apical foramen; second, newly differentiated odontoblasts should form on the existing dentinal wall of the root canal space; and finally, new dentin must be produced by the differentiated odontoblasts on the existing dentin.
2) Tooth reconstruction 
As our understanding of tooth formation, the stem cell niche and regenerative mechanisms extends, it may be possible to generate a method to biologically replace lost teeth. A functional biological replacement tooth must include generation of a root and periodontal ligament with nerve and blood supplies. The crown, although the most visible part of the tooth, is actually less important in terms of regeneration, since replacement of crowns with synthetic functioning options is possible.
3) Neurology 
Dental pulp cells have also been proposed as a treatment for peripheral nerve injury. Initially, dental pulp cells were transplanted into collagen gels and infused within a silicon tube, which was positioned within a 7 mm gap in the buccal branch of rat facial nerve. The dental pulp cells formed blood vessels and myelinating tissue and contributed to the promotion of normal nerve regeneration. In a subsequent study, a degradable poly (dl-lactide- co-glycolide) (PLGA) tube was developed to avoid the need for a potential second operation to remove the silicon tube.
4) Angiogenesis and vasculogenesis 
Stem cells and endothelial progenitor cells (EPCs) can be utilized to stimulate vasculogenesis as a potential treatment for ischaemic disease. Correspondingly therapeutic benefits of injection of bone marrow-or adipose- derived MSCs after myocardial infarction (MI) and other heart diseases have also been reported. Several studies have investigated the potential of DPSCs and sub-fractions of DPSCs as modes of treatment for MI and ischaemia.
5) Endocrinology  - 
Cell therapy treatments for liver disease require effective stem-cell derived hepatocytes. DPSCs have been differentiated to produce Hepatocyte-Like Cells (HLCs) with acquired hepatocyte functions, such as glycogen storage and urea production. Recently, hepatic differentiation of hDPSCs was undertaken using cryopreserved dental pulp tissue from teeth with disease. Differentiated cells possessed a polygonal shape and normal karyotype and expressed hepatic metabolic function genes and liver-specific genes. Glycogen storage and urea production results indicated that the differentiated hDPSCs were functionally close to normal hepatocyte-like cells (HLCs). Although research into hepatic differentiation of DPSCs is at an early stage, the use of cryopreserved tissue to generate HLCs provides a promising alternative for the treatment of liver diseases.
Stem cell-based therapy holds a great promise to solve health problems from both systemic and oral diseases. The identification of a good stem cell source is a major key for a success in tissue regeneration. Although stem cells can be isolated from a variety of tissues at various developmental stages with different stem cell capacities, human Dental Pulp Stem Cells (DPSCs), dental tissue-derived adult stem cells, have been widely studied due to their great clinical potential as a mesenchymal stem cell source, easy accessibility and less invasive harvesting.
Recently, the applications of DPSC in the dental field have been widely used. Most common application is pulp regeneration since pulpal pathology is commonly seen in the dental clinics; in addition pulp regeneration is extremely needed to preserve the infected pulp and protect the tooth from being non-vital.
Since the first discovery of DPSCs in 2000, studying in DPSCs grows rapidly. Nevertheless, there are still questionable issues needed to be optimized and answered such as the variable biological capacity of DPSCs.
Table A1. Details of the searched articles (narrative review).
 Potdar, P.D. and Jethmalani, Y.D. (2015) Human Dental Pulp Stem Cells: Applications in Future Regenerative Medicine. World Journal of Stem Cells, 7, 839-851.
 Potdar, P. and Sutar, J. (2010) Establishment and Molecular Characterization of Mesenchymal Stem Cell Lines Derived from Human Visceral & Subcutaneous Adipose Tissues. Journal of Stem Cells and Regenerative Medicine, 6, 26-35.